Published July 2015 | Version v1
Journal article

Methods of producing high specific activity Sn-117m with commercial cyclotrons

  • 1. Clear Vascular, Inc., The Woodlands, TX (United States)
  • 2. IsoTherapeutics Group LLC, Angleton, TX (United States)
  • 3. Brookhaven National Laboratory, Upton, NY (United States)
  • 4. US Radiopharmaceuticals, Denton, TX (United States)

Description

Sn-117m is a theragnostic isotope of increasing interest. It has ideal imaging and therapeutic properties for many applications. Production of high specific activity Sn-117m can only be achieved with accelerators and the Sb(p,x) and Cd-116(α,3n) reactions provide the highest yields for this isotope. This paper describes the production and a new purification method for obtaining commercial quantities of Sn-117m via the Cd-116(α,3n) reaction. The purified Sn-117m has subsequently been chelated with an aminobenzyl derivative of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and then conjugated with annexin V-128 to produce an agent for the diagnosis and treatment of vulnerable plaque. (author)

Additional details

Publishing Information

Journal Title
Journal of Radioanalytical and Nuclear Chemistry
Journal Volume
305
Journal Issue
1
Journal Page Range
p. 99-108
ISSN
0236-5731
CODEN
JRNCDM

Conference

Title
8. International Conference on Isotopes (ICI)
Dates
24-28 Aug 2014
Place
Chicago (United States)

Optional Information

Notes
29 refs.